C1 gene expression platform rapid, high yield and lower cost way to develop & manufacture biologics

Authors

• Mark Emalfarb, Dyadic International Inc., USA
• Ronen Tchelet, Dyadic International Inc., 1044 North US Hwy 1 Suite 201, USA
• Joseph Hazelton, Dyadic International Inc., 1044 North US Hwy 1 Suite 201, USA
• Noelia Valbuena, Dyadic International Inc., 1044 North US Hwy 1 Suite 201, USA

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Mark Emalfarb, Ronen Tchelet, Joseph Hazelton, and Noelia Valbuena, "C1 gene expression platform rapid, high yield and lower cost way to develop & manufacture biologics" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/62